Caplight Directory>Investors>Claris Ventures>Clarisventures


Claris Ventures

Claris Ventures

Turin, Piedmontclarisventures.com

Overview

Claris Ventures is a venture capital firm based in Italy, founded in 2019. Its first fund under management, Claris Biotech I, is focused on early stage investments in high potential biopharma companies. The firm seeks to invest in the biopharma sector, identifying and supporting innovation in the pharmaceutical space, investing in new companies with transformational drugs under development. Claris Ventures makes equity investments in early stage biopharma companies with a clear vision and solid scientific evidence.

Year Founded

2019

Portfolio Companies

7

Investments

CompanyDateStageLead
PAGE Therapeutics AGOct 2024SeedLead
NeoPhoreMay 2024Series B ExtensionCo-investor
Resalis TherapeuticsJan 2024Series ACo-investor
ALKemist BioDec 2023SeedLead
PAGE Therapeutics AGMay 2023Early FundingCo-investor
View all investments

Key People

Ciro Spedaliere

Founding Partner

Giulia Vestri

Partner

Pietro Puglisi

Partner

Paolo Vigo

Investment Manager

View all key people

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersTurin, Piedmont
Year Founded2019

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.